secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0000899923-25-000066
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad shareholders approve 6.5M share increase to 2017 equity plan; per-participant cap raised
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2017 Plan adding 6.5 million shares for equity grants.
- Board increased annual per-participant share cap from 500,000 to 574,040 shares.
- All three director nominees (Raha, Dreismann, Reitan) elected with >97% of votes cast.
- Advisory say-on-pay approved with 92% of votes cast in favor.
- Ernst & Young ratified as auditor for fiscal 2025 with 95.6% support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992325000066/0000899923-25-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992325000066/mygn-20250605.htm
  HTML page:      https://secwatch.observer/filing/0000899923-25-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer